Literature DB >> 10497210

The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis.

R K Reddy1, J Lu, A S Lee.   

Abstract

GRP94 is a 94-kDa chaperone glycoprotein with Ca(2+)-binding properties. We report here that during apoptosis induced by the topoisomerase II inhibitor etoposide, a fraction of GRP94 associated with the endoplasmic reticulum membrane undergoes specific proteolytic cleavage, coinciding with the activation of the caspase CPP32 and initiation of DNA fragmentation. In vivo, inhibitors of caspases able to block etoposide-induced apoptosis can only partially protect GRP94 from proteolytic cleavage, whereas complete inhibition is observed with calpain inhibitor I but not with the proteasome inhibitor. In vitro, GRP94 is not a substrate for CPP32; rather, it can be completely cleaved by calpain, a Ca(2+)-regulated protease. The cleavage of GRP94 by calpain is Ca(2+)-dependent and generates a discrete polypeptide of 80 kDa. In contrast, calpain has no effect on other stress proteins such as GRP78 or HSP70. Further, immunohistochemical staining reveals specific co-localization of GRP94 with calpain in the perinuclear region following etoposide treatment. We further showed that reduction of GRP94 by antisense decreased cell viability in etoposide-treated Jurkat cells. Our studies provide new evidence that the cytoprotective GRP94, as in the case of the antiapoptotic protein Bcl-2, can be targets of proteolytic cleavage themselves during the apoptotic process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497210     DOI: 10.1074/jbc.274.40.28476

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis.

Authors:  Wan-Ting Chen; Chun-Chih Tseng; Kyle Pfaffenbach; Gary Kanel; Biquan Luo; Bangyan L Stiles; Amy S Lee
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

Review 3.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

4.  Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation.

Authors:  Victoria Hung; Stephanie S Lam; Namrata D Udeshi; Tanya Svinkina; Gaelen Guzman; Vamsi K Mootha; Steven A Carr; Alice Y Ting
Journal:  Elife       Date:  2017-04-25       Impact factor: 8.140

5.  The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.

Authors:  Claudio Hetz; Milene Russelakis-Carneiro; Sébastien Wälchli; Sonia Carboni; Elisabeth Vial-Knecht; Kinsey Maundrell; Joaquín Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

6.  The stress protein/chaperone Grp94 counteracts muscle disuse atrophy by stabilizing subsarcolemmal neuronal nitric oxide synthase.

Authors:  Maurizio Vitadello; Jennifer Gherardini; Luisa Gorza
Journal:  Antioxid Redox Signal       Date:  2013-11-26       Impact factor: 8.401

7.  Calcium-dependent regulation of NEMO nuclear export in response to genotoxic stimuli.

Authors:  Craig M Berchtold; Zhao-Hui Wu; Tony T Huang; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

8.  Targeted mutation of the mouse Grp94 gene disrupts development and perturbs endoplasmic reticulum stress signaling.

Authors:  Changhui Mao; Miao Wang; Biquan Luo; Shiuan Wey; Dezheng Dong; Robin Wesselschmidt; Stephen Rawlings; Amy S Lee
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 9.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

10.  Alterations in molecular chaperones and eIF2alpha during lung endothelial cell apoptosis.

Authors:  Qing Lu; Matthew Jankowich; Julie Newton; Elizabeth O Harrington; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-22       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.